Skip to content

Young Smokers Have Impaired Airway Defense

Young Smokers Have Impaired Airway Defense That is Not Associated With Pulmonary Function

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01877291
Enrollment
72
Registered
2013-06-13
Start date
2012-04-30
Completion date
2012-11-30
Last updated
2013-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking

Keywords

smoking, nasal lavage, exhaled breath condensate, mucociliary transport

Brief summary

Background: Smoking is a key factor for development and progression of chronic obstructive pulmonary disease (COPD). Although persons with COPD often have concomitant nasal disease, there are few studies that report physiological or inflammatory changes in the upper airways in young asymptomatic smokers. The investigators investigated physiologic and inflammatory changes in the nasal and lower airways of young smokers and if these changes were related to smoking history. Methods: Seventy-two subjects aged ≤ 35 years (32 healthy nonsmokers and 40 young smokers) participated in this study. The investigators measured nasal mucociliary clearance (MCC), nasal mucus physical properties, cell count, myeloperoxidase and cytokines concentrations in nasal lavage fluid, exhaled breath condensate (EBC) pH and lung function.

Interventions

None listed

Sponsors

Fundação de Amparo à Pesquisa do Estado de São Paulo
CollaboratorOTHER_GOV
University of Sao Paulo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy nonsmokers * asymptomatic smokers * after obtaining written informed consent

Exclusion criteria

* inability to understand and follow commands * previous nasal surgery * respiratory infection in the previous 30 days * reported or diagnosed asthma

Design outcomes

Primary

MeasureTime frame
Exhaled Breath Condensate pHsix months

Secondary

MeasureTime frame
mucociliary clearance by saccharine transit time testsix months

Other

MeasureTime frame
cytokines in nasal lavagesix months

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026